Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 54 holding rows worth $4,017,507,000.

Accession
0001534261-21-000008
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 54 entries on the cover page, a total value of $4,017,507,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,017,507,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVITAE CORP46185L103COM12,203,669$346,950,000thousands by filing date
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock7,566,292$320,205,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock2,360,186$225,280,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock7,990,652$204,161,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM3,400,000$201,518,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock1,000,000$188,810,000thousands by filing date
MAXCYTE INC57777K106COM13,971,334$170,590,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM1,550,000$159,356,000thousands by filing date
SOMALOGIC INC83444K105COM12,389,082$153,501,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM3,038,167$142,794,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock3,668,574$115,670,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM1,000,000$106,970,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,100,000$101,728,000thousands by filing date
CODEXIS INC192005106COM4,330,000$100,716,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM2,165,000$99,915,000thousands by filing date
ABSCI CORPORATION00091E109COM7,718,593$89,767,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock1,700,000$85,765,000thousands by filing date
GINKGO BIOWORKS HOLDINGS INC37611X100CL A SHS7,202,808$83,481,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM3,206,380$80,673,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock2,800,000$77,028,000thousands by filing date
CAREDX INC14167L103COM1,193,335$75,622,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM3,586,818$74,068,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM818,820$71,246,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM5,487,910$70,959,000thousands by filing date
DERMTECH INC24984K105COM1,745,000$56,032,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR150,000$54,450,000thousands by filing date
ALLOGENE THERAPEUTICS INC019770106COM2,100,000$53,970,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,925,000$49,049,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock1,440,000$48,946,000thousands by filing date
SEMA4 HOLDINGS CORP81663L101COM5,000,000$37,950,000thousands by filing date
ALECTOR INC014442107COMMON STOCK1,650,000$37,653,000thousands by filing date
GENERATION BIO CO37148K100COM1,324,275$33,200,000thousands by filing date
SINGULAR GENOMICS SYSTEMS IN82933R100COM2,692,870$30,133,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock1,115,455$30,084,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock266,430$29,822,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock3,901,589$28,404,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM1,200,000$22,932,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM960,883$21,408,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR190,000$20,024,000thousands by filing date
23ANDME HOLDING CO90138Q108CLASS A COM1,841,457$16,684,000thousands by filing date
908 DEVICES INC COM65443P102Stock406,502$13,219,000thousands by filing date
RECURSION PHARMACEUTICALS IN75629V104CL A548,156$12,613,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM601,515$12,578,000thousands by filing date
KRONOS BIO INC50107A104COM583,436$12,229,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM50,000$9,070,000thousands by filing datecall
DECIBEL THERAPEUTICS INC24343R106COM1,170,048$9,021,000thousands by filing date
ALPHA TEKNOVA INC02080L102COMMON STOCK300,000$7,467,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR2,575,000$5,923,000thousands by filing date
SEER INC81578P106COM CL A150,000$5,180,000thousands by filing date
BERKELEY LTS INC084310101COM200,000$3,912,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM120,000$3,053,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK215,000$2,995,000thousands by filing date
NAUTILUS BIOTECHNOLOGY INC63909J108COM225,000$1,382,000thousands by filing date
SANA BIOTECHNOLOGY INC799566104COM60,000$1,351,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001534261-21-000008this filing2021-11-15acceptance time not in the bulk data set